Angio-oedema and urticaria associated with angiotensin converting enzyme inhibitors.
about
Angio-oedema in relation to treatment with angiotensin converting enzyme inhibitorsTolerability of long term therapy with enalapril maleate in patients resistant to other therapies and intolerant to captoprilEffects of intradermal bradykinin after inhibition of angiotensin converting enzyme.Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277Effect of enalapril on allergen-induced cutaneous hypersensitivity reaction.The effects of intradermal bradykinin are potentiated by angiotensin converting enzyme inhibitors in hypertensive patients.A comparison of the effects of captopril and enalapril on skin responses to intradermal bradykinin and skin blood flow in the human forearm.Review of yellow cards (1986): report to the Committee on the Safety of Medicines.Fimasartan, a novel angiotensin II receptor antagonist.Angioedema due to ACE inhibitors: increased risk in patients of African origin.Angiotensin-converting enzyme inhibitor (ACE-I)- and angiotensin receptor blocker (ARB)-related angioedema: a neglected issue in daily practice in Greece.Risk factors associated with severe and recurrent angioedema: an epidemic linked to ACE-inhibitors.Angiotensin-converting enzyme inhibitors and their influence on inflammation, bronchial reactivity and cough. A research review.Angiotensin II receptor blockade: an innovative approach to cardiovascular pharmacotherapy.The effects of enalapril and sulindac on the dermal response to substance P and neurokinin A.Chronic urticaria and use of statins.Severe angioedema and respiratory distress associated with lisinopril useAngioedema of the head and neck and angiotensin-converting enzyme inhibitors.Epidemiological study of angioedema and ACE inhibitors.
P2860
Q28319778-622BD693-334D-455B-9AAF-911749D15F61Q28342526-F477401C-A4FC-4B87-9C96-F23AB0EA384EQ28360579-1EC70CBC-4B3A-492D-85C6-3A060891185EQ28378315-5EFB2116-B8E2-40A6-8C65-1347BC218DEDQ34358761-9B78769D-6E29-444F-B27E-9266F0F9A452Q34397424-3492683A-9021-42AF-916C-5612CE1929DEQ34403454-670DA271-0D61-400F-A2B0-CEC2861AAC49Q34418158-FB86B5FB-F41A-4764-AC00-BBAA2E89045BQ34641179-0254C3AC-EAAD-4711-9925-A61464EC6550Q36053645-05C98DAA-7535-4841-BF0A-3E5B15E0406BQ37103795-F35A55AE-8F43-440A-AE7A-255F5A48A500Q38221036-61405474-611B-4C6D-A44B-1FBFFEDF06DDQ38715065-ACE48F6B-C788-43EF-9308-45FA1A09B6DAQ40811095-F4AAA680-DAC0-45D1-BC0A-C863084AC5F8Q42057799-95D28617-0925-4719-BAD6-998A11ECACA8Q42088266-879561E7-27C1-4CFE-9153-3E5C0A9D78E2Q42178000-8321AF60-445D-49FE-AD2E-4F8F6BCA7ACDQ43502815-9F276111-4CEE-437E-A3C9-F32CD281799DQ50974591-8E84A9A8-A4E0-46E5-ADFC-03EF510AFF52
P2860
Angio-oedema and urticaria associated with angiotensin converting enzyme inhibitors.
description
1987 nî lūn-bûn
@nan
1987 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Angio-oedema and urticaria associated with angiotensin converting enzyme inhibitors
@nl
Angio-oedema and urticaria associated with angiotensin converting enzyme inhibitors.
@ast
Angio-oedema and urticaria associated with angiotensin converting enzyme inhibitors.
@en
type
label
Angio-oedema and urticaria associated with angiotensin converting enzyme inhibitors
@nl
Angio-oedema and urticaria associated with angiotensin converting enzyme inhibitors.
@ast
Angio-oedema and urticaria associated with angiotensin converting enzyme inhibitors.
@en
prefLabel
Angio-oedema and urticaria associated with angiotensin converting enzyme inhibitors
@nl
Angio-oedema and urticaria associated with angiotensin converting enzyme inhibitors.
@ast
Angio-oedema and urticaria associated with angiotensin converting enzyme inhibitors.
@en
P2093
P2860
P356
P1433
P1476
Angio-oedema and urticaria associated with angiotensin converting enzyme inhibitors.
@en
P2093
P2860
P356
10.1136/BMJ.294.6564.91
P407
P577
1987-01-01T00:00:00Z